Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection-Reference-Cited by-同舟云学术

Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection

Published:2013-09-09 Issue:7 Volume:49 Page:650-658
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Milla Carlos E.¹,Chmiel James F.²,Accurso Frank J.³,VanDevanter Donald R.²,Konstan Michael W.²,Yarranton Geoffrey⁴,Geller David E.⁵,

Affiliation:

1. Center For Excellence in Pulmonary Biology; Stanford University; Palo Alto California

2. Department of Pediatrics; Case Western Reserve University School of Medicine; Cleveland Ohio

3. The Children's Hospital of Denver, University of Colorado; Denver Colorado

4. KaloBios Pharmaceuticals, Inc.; South San Francisco California

5. Florida State University College of Medicine; Orlando Florida

Funder

KaloBios Pharmaceuticals, Inc., CFTDN

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.22890/fullpdf

Reference55 articles.

1. Cystic fibrosis: state of the art;Davis;Am J Respir Crit Care Med,1996

2. The changing microbial epidemiology in cystic fibrosis;LiPuma;Clin Microbiol Rev,2010

3. Pseudomonas aeruginosa infection in cystic fibrosis: diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immune electrophoresis;Høiby;Scand J Respir Dis,1977

4. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group;Ramsey;N Engl J Med,1999

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An escape from ESKAPE pathogens: A comprehensive review on current and emerging therapeutics against antibiotic resistance;International Journal of Biological Macromolecules;2024-11

2. Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal Pseudomonas aeruginosa infection via inhibition of toxin translocation by the type III secretion system;Antimicrobial Agents and Chemotherapy;2024-09-13

3. Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections;Clinical Microbiology Reviews;2024-09-12

4. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response;Frontiers in Immunology;2024-06-28

5. AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from lethal Pseudomonas aeruginosa pneumonia;Gene Therapy;2024-04-27